One Month Weight Loss Predicts the Efficacy of Liraglutide in Obese Patients: Data from A Single Center-Reference-Cited by-同舟云学术

One Month Weight Loss Predicts the Efficacy of Liraglutide in Obese Patients: Data from A Single Center

Published:2020-02 Issue:2 Volume:26 Page:235-240
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Maccora Carla,Ciuoli Cristina,Goracci Arianna,Benenati Nicoletta,Formichi Caterina,Pilli Tania,Verdino Valeria,Mnutr Ornella Neri,Bufano Annalisa,Tirone Andrea,Voglino Costantino,Fagiolini Andrea,Castagna Maria Grazia

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference13 articles.

1. Benefits of modest weight loss in improving cardiovascular risk factors in over-weight and obese individuals with type 2 diabetes;Wing;Diabetes Care,2011

2. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS;Van Bloemendaal;J Endocrinol,2014

3. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond;Prasad-Reddy;Drugs in Context,2015

4. GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?;Brunton;Int J Clin Pract,2014

5. A randomized, controlled trial of 3.0 mg of liraglutide in weight management;Pi-Sunyer;N Engl J Med,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Super response to liraglutide in people with obesity: A case report and literature review;Endocrinología, Diabetes y Nutrición;2024-08

2. GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review;Journal of Clinical & Translational Endocrinology;2024-03

3. Review on Predictors of Weight Loss in Moderate to Severe Obesity Treatment;Journal of Korean Medicine for Obesity Research;2023-12-31

4. Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis;Obesity;2023-11-21

5. Potential contributors to variation in weight‐loss response to liraglutide;Obesity Reviews;2023-04-17